Pipeline Moves

Pipeline Moves: Pfizer’s flu vaccine approval chances rise after Phase III completion

Pipeline Moves: Progression prospects for stuttering candidate increase after trial completion

Pipeline moves: Approval prospects for SBS candidate rise after Phase III trial meets endpoints

Pipeline moves: Prospects drop after investigator-led trial of Roche’s Tecentriq terminated

Pipeline Moves: Approval prospects for ALL candidate rise after Phase III completion

Features

Pipeline Moves: Approval prospects for Roche’s tiragolumab rise in oesophageal squamous cell carcinoma

This week on Pipeline Moves, we kick off by looking at a Phase III trial by Roche in its oesophageal…

Features

Pipeline Moves: Approval chances for thalassaemia candidate rise after Phase III trial meets endpoints.

This week on Pipeline Moves, we kick off by looking at a Phase III trial in alpha thalassaemia and beta…

Features

Pipeline Moves: Phase III bronchiectasis trial terminated due to recruitment issues

This week on Pipeline Moves, we kick off by looking at the termination of a Phase III trial in non-cystic…